Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
543,520
-
Share change
-
-274,294
-
Total reported value
-
$3,371,822
-
Price per share
-
$6.37
-
Number of holders
-
14
-
Value change
-
-$1,225,552
-
Number of buys
-
7
-
Number of sells
-
10
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2015
As of 31 Mar 2015,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
543,520 shares.
The largest 10 holders included
AWM Investment Company, Inc., GREYLIN INVESTMENT MANGEMENT INC, TOCQUEVILLE ASSET MANAGEMENT L.P., HSBC HOLDINGS PLC, TWO SIGMA SECURITIES, LLC, MORGAN STANLEY, FineMark National Bank & Trust, GROUP ONE TRADING, L.P., UBS Group AG, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.